Sun’s Specialty Gambit Paying Off, Tildrakizumab Nears Sales Milestone

About 9,000 US physicians have prescribed Winlevi

sales surge
Sun's Specialty Business Sees Uptick • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip